{"studyId":"mixed_selpercatinib_2020","cancerTypeId":"mixed","name":"Mixed Tumors Selpercatinib RET Trial (MSK, Nat Commun. 2022)","description":"Targeted sequencing of Selpercatinib treated RET-driven solid cancers.","publicStudy":true,"pmid":"35304457","citation":"Ezra Y et al. Nat Commun 2022","groups":"","status":1,"importDate":"2026-01-08 16:41:27","allSampleCount":188,"sequencedSampleCount":185,"cnaSampleCount":60,"mrnaRnaSeqSampleCount":0,"mrnaRnaSeqV2SampleCount":0,"mrnaMicroarraySampleCount":0,"miRnaSampleCount":0,"methylationHm27SampleCount":0,"rppaSampleCount":0,"massSpectrometrySampleCount":0,"completeSampleCount":0,"referenceGenome":"hg19","treatmentCount":0,"structuralVariantCount":51,"cancerType":{"id":"mixed","name":"Mixed Cancer Types","dedicatedColor":"Black","shortName":"MIXED","parent":"other"},"readPermission":true,"resourceCounts":[]}